Thermo Fisher Scientific | TMO - Себестоимость





Себестоимость Изменить Дата
Abbott USD 5.94B 642M 2026-06
Agilent USD 845M 7M 2026-03
Becton, Dickinson and Co. USD 2.56B 281M 2026-03
Bio Techne USD 103.13M 1.47M 2026-03
Bio-Rad Laboratories USD 348M 38.4M 2025-12
Boston Scientific USD 1.83B 8M 2026-03
Bruker USD 443.6M 84.4M 2026-03
Charles River Laboratories USD 716.51M 5.76M 2026-03
Danaher USD 2.36B 512M 2026-03
Dentsply International USD 453M 65M 2026-03
Edwards Lifesciences USD 362.6M 19.6M 2026-03
General Electric Aerospace USD 8.89B 736M 2026-06
Henry Schein USD 2.3B 145M 2026-03
Illumina USD 370M 30M 2026-03
Intuitive Surgical USD 931.9M 8.4M 2026-06
IQVIA Holdings USD 3.08B 161M 2026-03
Laboratory Of America USD 2.6B 4.2M 2026-03
Medtronic USD 3.8B 195M 2026-03
Mettler Toledo International USD 410.92M 63.05M 2026-03
Myriad Genetics USD 63M 1.1M 2025-12
Olympus JPY 102.52B 6.38B 2026-03
OraSure Technologies USD 15.43M 113K 2025-12
Quest Diagnostics USD 1.99B 57M 2026-03
Repligen USD 85.97M 8.11M 2026-03
Revvity USD 323.46M 26.93M 2026-03
Stryker USD 2.36B 325M 2026-03
Thermo Fisher Scientific USD 6.96B 620M 2026-03
Veracyte USD 38.49M 794K 2026-03
Waters USD 725M 350.06M 2026-03
Zimmer Biomet Holdings USD 738.3M 231.8M 2026-03